| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 02/21/2012 | US8119614 Substitution derivatives of N6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 02/21/2012 | CA2540109C Method for stabilization of diarylvinylene compounds |
| 02/21/2012 | CA2248800C Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 02/16/2012 | US20120040982 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 02/16/2012 | US20120040924 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections |
| 02/16/2012 | US20120040918 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 02/15/2012 | CN102349914A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/14/2012 | US8114994 2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment viral infections and abnormal cellular proliferation |
| 02/14/2012 | US8114877 Organic compounds |
| 02/09/2012 | US20120035192 Selective antagonists of a2a adenosine receptors |
| 02/09/2012 | US20120035158 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 02/08/2012 | EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors |
| 02/08/2012 | EP2414362A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors |
| 02/08/2012 | EP2414361A1 Substituted heterocyclic compounds |
| 02/08/2012 | EP2414044A1 Substituted indolo-piperidine compounds |
| 02/08/2012 | CN102344451A Method for preparing caffeine |
| 02/08/2012 | CN102344450A Method for extracting theophylline sodium salt or theophylline by styrene type macroporous resin |
| 02/02/2012 | US20120028995 Novel compounds for medical use as peptidase effectors |
| 02/01/2012 | EP2412373A1 Method for preparing acyclovir 2/3 hydrate |
| 02/01/2012 | EP2411392A2 Novel crystal forms of adefovir dipivoxil and processes for preparing the same |
| 02/01/2012 | EP2411391A1 Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| 02/01/2012 | CN102336755A Chemical synthesis method of 6-chloropurine |
| 02/01/2012 | CN102336754A Method for synthesizing entecavir and intermediate compound thereof |
| 02/01/2012 | CN101863842B 恩替卡韦中间体及合成方法 Entecavir intermediates and synthesis methods |
| 01/31/2012 | US8106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
| 01/26/2012 | US20120022086 Catecholamine derivatives for obesity and neurological disorders |
| 01/26/2012 | US20120022085 Process for obtaining extracts containing methylxanthine derivatives from cakes of plants of the genus theobroma, as well as composition and use of said extract |
| 01/25/2012 | EP2408775A1 Oxidated derivatives of triazolypurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| 01/25/2012 | EP2408774A2 Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof |
| 01/25/2012 | CN102329317A Method for synthesizing theobromine |
| 01/24/2012 | US8101588 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 01/24/2012 | CA2496249C 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 01/19/2012 | WO2012007493A1 Purine compounds selective for ρi3κ p110 delta, and methods of use |
| 01/19/2012 | WO2012006964A1 Entecavir synthesis method and intermediate compound thereof |
| 01/19/2012 | US20120015964 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/19/2012 | US20120015937 Kinase Inhibitors And Their Uses |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | CA2802808A1 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/18/2012 | EP2405917A2 Substituted fused pyrimidine compounds |
| 01/18/2012 | EP1877411B1 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
| 01/18/2012 | EP1256574B1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 01/18/2012 | CN102321086A Synthesizing method of adenine |
| 01/18/2012 | CN101759698B Method for preparing entecavir |
| 01/17/2012 | US8097723 Process for the preparation of abacavir |
| 01/17/2012 | CA2451244C Purine derivatives as a2b adenosine receptor antagonists |
| 01/12/2012 | WO2012003576A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 01/12/2012 | US20120010408 Method for Preparing Acyclovir 2/3 Hydrate |
| 01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
| 01/12/2012 | CA2803448A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 01/11/2012 | EP2403839A2 Neurotrophin mimetics and uses thereof |
| 01/11/2012 | CN202107650U Recovery unit for recovering theophylline sodium salt from theophylline sodium salt mother liquor |
| 01/11/2012 | CN101805339B Entecavir compound preparation method |
| 01/10/2012 | CA2556073C 8-chloro-1,3-disubstituted xanthine derivatives as hm74a receptor modulators |
| 01/10/2012 | CA2505389C Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 01/05/2012 | WO2012003264A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
| 01/05/2012 | US20120004248 Methods of using a methylxanthine compound |
| 01/05/2012 | US20120004246 Purinyl derivatives and their use as potassium channel modulators |
| 01/05/2012 | US20120004212 Organic compounds |
| 01/05/2012 | CA2803620A1 Heterocyclic compounds and their uses |
| 01/04/2012 | EP2402341A2 Purinyl derivatives and their use as potassium channel modulators |
| 01/04/2012 | EP2402334A1 Inhibitors of E1 Activating Enzymes |
| 01/03/2012 | CA2494183C Processes for preparing 1,3-dioxolane nucleosides |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 12/29/2011 | WO2011163424A2 Substituted 2-(9h-purin-9-yl) acetic acid analogues as inhibitors of stat3 |
| 12/29/2011 | WO2011163355A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 12/29/2011 | WO2011163195A1 Fused pyrrole derivatives as pi3k inhibitors |
| 12/29/2011 | US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation |
| 12/29/2011 | US20110319394 Fused heterocyclic compounds |
| 12/29/2011 | CA2813571A1 Substituted 2-(9h-purin-9-yl) acetic acid analogues as inhibitors of stat3 |
| 12/29/2011 | CA2803156A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 12/28/2011 | EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 12/27/2011 | US8084458 Synthesis of locked nucleic acid derivatives |
| 12/22/2011 | WO2011158252A1 Process for the preparation of valacyclovir hydrochloride polymorphic form ii |
| 12/22/2011 | WO2011156889A1 Novel modulators of nrf2 and uses thereof |
| 12/22/2011 | US20110312980 Small-molecule Hsp90 Inhibitors |
| 12/22/2011 | US20110312979 Fused pyrrole derivatives as pi3k inhibitors |
| 12/22/2011 | US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1 |
| 12/21/2011 | EP2396328A2 Toll-like receptor modulators and treatment of diseases |
| 12/20/2011 | US8080555 Purine derivatives and their use for treatment of autoimmune diseases |
| 12/20/2011 | CA2525037C Microcrystals of (e)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 12/15/2011 | WO2011156632A2 Compositions and methods of treatment for tumors in the nervous system |
| 12/15/2011 | WO2010129053A8 Egfr inhibitors and methods of treating disorders |
| 12/15/2011 | US20110306610 9-substituted 8-oxoadenine compound |
| 12/14/2011 | CN102276610A N<sup>7</sup>-鸟嘌呤烷化物的制备方法 Preparation of alkylate guanine - N <sup> 7 </ sup> |
| 12/14/2011 | CN102276609A 氨基哌啶黄嘌呤盐酸盐、其制备方法及其用途 Aminopiperidine xanthine hydrochloride, its preparation and use |
| 12/14/2011 | CN101787027B 高纯度cbz-伐昔洛韦的制备方法 High purity cbz- valacyclovir preparation |
| 12/14/2011 | CN101089010B 2＇-氟代核苷 2'-fluoro nucleosides |
| 12/13/2011 | US8076338 Such as 6-(4-phenylpiperazin-1-yl)-9H-purine; cell proliferation/differentiation |
| 12/08/2011 | WO2011152351A1 Purinone derivative |
| 12/08/2011 | WO2011151360A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 12/08/2011 | WO2011150513A1 Carbanucleoside synthesis and novel intermediate compounds useful therein |
| 12/08/2011 | WO2011150512A1 Process for the synthesis of carbonucleoside and intermediates for use therein |
| 12/08/2011 | US20110301183 Chemical synthesis of a highly potent epothilone |
| 12/08/2011 | US20110301158 Aryl carbonyl derivatives as therapeutic agents |
| 12/08/2011 | CA2801128A1 Carbanucleoside synthesis and novel intermediate compounds useful therein |
| 12/08/2011 | CA2800523A1 Purinone derivative |
| 12/08/2011 | CA2800367A1 Process for the synthesis of carbonucleoside and intermediates for use therein |
| 12/07/2011 | EP2392580A1 2'-fluoronucleosides |
| 12/07/2011 | EP2391626A2 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
| 12/06/2011 | US8071609 Unsaturated heterocyclic derivatives |